“Antimyosin Agents as Potential Treatment for Left Ventricular Diastolic Dysfunction in Hypertrophic Cardiomyopathy and Heart Failure with Preserved Ejection Fraction”

https://pubmed.ncbi.nlm.nih.gov/38113298

Increased chamber resting tone is the primary cause of left ventricular diastolic dysfunction in hypertrophic cardiomyopathy and heart failure with preserved ejection fraction, and antimyosin agents may be a potential treatment.